MINI REVIEW article

Front. Neurol.

Sec. Neuro-Oncology and Neurosurgical Oncology

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1568898

This article is part of the Research TopicEvolving Strategies in Radiation Therapy for Benign Intracranial Tumors: Current Techniques, Clinical Challenges, and Future ProspectsView all 3 articles

Recent Technology Development in Radiotherapy for Intracranial Meningiomas

Provisionally accepted
Rebecca UngarRebecca Ungar1Joshua Kilian-MeneghinJoshua Kilian-Meneghin2Brett EckorateBrett Eckorate2Sabin MotwaniSabin Motwani2Ning YueNing Yue2Ke NieKe Nie2Zhenyu XiongZhenyu Xiong2Yin ZhangYin Zhang2*
  • 1Department or Physics and Astronomy, Rutgers University, Piscataway, NJ 08854, United States
  • 2Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, United States

The final, formatted version of the article will be published soon.

Select one of your emails

You have multiple emails registered with Frontiers:

Notify me on publication

Please enter your email address:

If you already have an account, please login

You don't have a Frontiers account ? You can register here

Meningiomas are the most common central nervous system (CNS) tumors in the United States.Radiotherapy plays an important role in the management of meningiomas and has been established as an effective means of local tumor control. The recent technology development in artificial intelligence, understanding of meningioma biology and molecular imaging, will likely impact the clinical management of meningiomas, including treatment efficacy, efficiency and safety. This review summarizes recent technological advances that may influence radiotherapy management for meningiomas, including external beam radiation therapy, proton therapy and brachytherapy.

Keywords: Radiotherapy, Brachytherapy, Proton therapy, Gammaknife, CyberKnife, artificial intelligence, meningiomas

Received: 30 Jan 2025; Accepted: 11 Apr 2025.

Copyright: © 2025 Ungar, Kilian-Meneghin, Eckorate, Motwani, Yue, Nie, Xiong and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yin Zhang, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Supplementary Material